Ö. Gumusay Et Al. , "Immunotherapy toxicity: identification and management," BREAST CANCER RESEARCH AND TREATMENT , vol.192, no.1, pp.1-17, 2022
Gumusay, Ö. Et Al. 2022. Immunotherapy toxicity: identification and management. BREAST CANCER RESEARCH AND TREATMENT , vol.192, no.1 , 1-17.
Gumusay, Ö., Callan, J., & Rugo, H. S., (2022). Immunotherapy toxicity: identification and management. BREAST CANCER RESEARCH AND TREATMENT , vol.192, no.1, 1-17.
Gumusay, ÖZGE, J. Callan, And H. S. Rugo. "Immunotherapy toxicity: identification and management," BREAST CANCER RESEARCH AND TREATMENT , vol.192, no.1, 1-17, 2022
Gumusay, ÖZGE Et Al. "Immunotherapy toxicity: identification and management." BREAST CANCER RESEARCH AND TREATMENT , vol.192, no.1, pp.1-17, 2022
Gumusay, Ö. Callan, J. And Rugo, H. S. (2022) . "Immunotherapy toxicity: identification and management." BREAST CANCER RESEARCH AND TREATMENT , vol.192, no.1, pp.1-17.
@article{article, author={ÖZGE GÜMÜŞAY Et Al. }, title={Immunotherapy toxicity: identification and management}, journal={BREAST CANCER RESEARCH AND TREATMENT}, year=2022, pages={1-17} }